Orthofix International Launches Three New Sports Medicine Products

May 20, 2010

BOSTON, May 20, 2010 (BUSINESS WIRE) -- Orthofix International (NASDAQ: OFIX) (the Company) announced today that its sports medicine division, Breg, has introduced three new products, including a soft knee brace with an integrated hinge for added stability, a hip pad to be used with its cold therapy devices for post surgery pain management, and a wrist immobilization accessory for its T-Scope Elbow brace.

The Company also introduced the OrthoFind app, one of the first iPhone applications for the orthopedics market, designed to assist health care providers in choosing products for their patients directly from their mobile phones.

Lateral Stabilizer with Hinge provides comfort with stability

The newest product in Breg's line of soft knee braces is the Lateral Stabilizer with Hinge. The brace is designed to enhance knee stability and provide pain relief for patients suffering from a range of conditions affecting the kneecap, and to also be eligible for coverage under patients' health care insurance. Available in Airmesh(R) breathable fabric and neoprene, the low profile brace is intended to maximize the patient's comfort while providing minimal interference. The U.S. market for soft knee braces and immobilizers is projected to be approximately $345.1 million in 2010.

Hip Pad Brings Pain Management to Joint Replacement Patients

The Polar Care(R) Kodiak(R) Intelli-Flo Hip Pad provides cold therapy pain management during post-operative care and rehabilitation for patients recovering from hip surgery. Ergonomically designed for comfort and coverage of the hip, the Intelli-Flo Hip Pad's unique flow channel directs water circulation throughout the pad, with additional circulation at the incision site. An estimated 625,000 total or partial hip replacements will be performed in the U.S. in 2010.

T-Scope Elbow Neutral Hand Accessory for Wrist Immobilization

Breg's Neutral Hand Accessory extends the functionality of its T-Scope Elbow brace. Designed to provide the patient with comfort and control while restricting wrist motion, the new device is intended for patients with elbow injuries, including tendon and ligament ailments such as tennis elbow. The U.S. market for upper extremity supports is expected to reach approximately $53.7 million in 2010.

OrthoFind Mobile Application

Developed for the Apple iPhone and iTouch devices, the OrthoFind app provides mobile access to Breg's catalog of bracing and cold therapy products. The app includes product descriptions, indications, Medicare coding and ordering information. It also offers the latest news on orthopedic procedures and surgeries, provides frequently asked questions about the industry, and lets users join and interact with the OrthoFind community. Products are searchable by anatomy, category or keyword. It is estimated that 80 percent of physicians will be using smart phones by 2012. The OrthoFind app is free to download from the Apple Apps Store (http://www.apple.com/iphone/apps-for-iphone/).

About Orthofix

Orthofix International, N.V. is a global medical device company offering a broad line of minimally invasive surgical, and non-surgical, products for the spine, orthopedic, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages-helping them achieve a more active and mobile lifestyle. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, including BREG, Inc. and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading medical institutions such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, The University of Medicine and Dentistry of New Jersey and the National Osteoporosis Institute. For more information about Orthofix, please visit www.orthofix.com.

SOURCE: Orthofix International

Orthofix International
Dan Yarbrough, 617-912-2903
Vice President of Investor Relations

Copyright Business Wire 2010